Ozempic
Product Images NDC 50090-5138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 70 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 50090-5138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

→ Structural Formula (image 01)

→ Figure 1 (image 02)

→ Figure 2 (image 03)

→ Figure 3 (image 04)

→ Figure 4 (image 05)

→ Figure 5 (image 06)

→ Warning 1 (image 07)

→ Device 1 (image 08)

→ A (image 09)

→ B (image 10)

→ C (image 11)

→ D (image 12)

→ E (image 13)

→ F (image 14)

→ Warning 2 (image 15)

→ Dose 1 (image 16)

→ G (image 17)

→ H (image 18)

→ Warning 3 (image 19)

→ Dash 1 (image 20)

→ I (image 21)

→ Warning 4 (image 22)

→ J (image 23)

→ K (image 24)

→ L (image 25)

→ M (image 26)

→ N (image 27)

→ O (image 28)

→ Warning 5 (image 29)

→ P (image 30)

→ Q (image 31)

→ R (image 32)

→ S (image 33)

→ Warning 6 (image 34)

→ Warning 7 (image 35)

→ Qr1 (image 36)

→ Bull 1 (image 37)

→ Warning 8 (image 38)

→ Device 2 (image 39)

→ A (image 40)

→ B (image 41)

→ C (image 42)

→ D (image 43)

→ E (image 44)

→ F (image 45)

→ Warning 9 (image 46)

→ Dose 2 (image 47)

→ G (image 48)

→ H (image 49)

→ Warning 10 (image 50)

→ Dash 2 (image 51)

→ I (image 52)

→ Warning 11 (image 53)

→ J (image 54)

→ K (image 55)

→ L (image 56)

→ M (image 57)

→ N (image 58)

→ O (image 59)

→ Warning 12 (image 60)

→ P (image 61)

→ Q (image 62)

→ R (image 63)

→ S (image 64)

→ Warning 13 (image 65)

→ Warning 14 (image 66)

→ Qr2 (image 67)

→ Bull 2 (image 68)

→ Figure 6 (image 71)

→ Label Image (lbl500905138)

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Figure 1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

This is a report on the relative exposure of Semaglutide in different demographics based on their age, weight, ethnicity, and renal function. The report shows the ratio and 90% CT of the intrinsic factor relative exposure (Cavg) for different categories such as sex, race, ethnicity, body weight, and renal impairment. The report also presents the Semaglutide exposure (Cavg) relative to a reference subject profile of non-Hispanic/Latino, White, female below 65 years, 85 kg body weight, with normal renal function, and includes maintenance dose and injection site as covariates. Overall, the report provides useful information about the relative exposure of Semaglutide in various demographic factors.*

FDA Label Image